Kangsheng Liao
Dongguan Key Laboratory For Pathogenesis And Experimental Diagnosis Of Infectious Diseases
Dongguan, 523808, China
Dongguan, 523808, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Immune defense and immune evasion in Mycobacterium tuberculosis Infection: Inspirations and challenges for host directed therapy.
Journal: Microbial pathogenesis
Published: May 22, 2025
Microneedle-based sustained release delivery of TNF-α/IL-6R dual-specific fenobody alleviates inflammation and promotes bone regeneration in rheumatoid arthritis rat model.
Journal: Materials today. Bio
Published: January 31, 2025
Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance.
Journal: Journal of nanobiotechnology
Published: August 01, 2023
Advances of MnO2 nanomaterials as novel agonists for the development of cGAS-STING-mediated therapeutics.
Journal: Frontiers in immunology
Published: February 01, 2023
Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.
Journal: Frontiers in cellular and infection microbiology
Published: October 19, 2022
Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development.
Journal: Frontiers in immunology
Published: May 30, 2022
Sinomenine protects bone from destruction to ameliorate arthritis via activating p62Thr269/Ser272-Keap1-Nrf2 feedback loop.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 25, 2020
Improvement of glucocorticoid-impaired thymus function by dihydromyricetin via up-regulation of PPARγ-associated fatty acid metabolism.
Journal: Pharmacological research
Published: August 03, 2018
Atomic force microscopy technique used for assessment of the anti-arthritic effect of licochalcone A via suppressing NF-κB activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 13, 2018
Licochalcone A activates Keap1-Nrf2 signaling to suppress arthritis via phosphorylation of p62 at serine 349.
Journal: Free radical biology & medicine
Published: July 13, 2017
Last Updated: 09/26/2026